Nav: Home

Intermountain healthcare honored by the CDC for protocols to reduce blood clots

March 31, 2016

Intermountain Healthcare is one of eight health systems and hospitals nationwide that were recognized Tuesday by the U.S. Centers for Disease Control and Prevention for implementing protocols that have helped to reduce the rate of venous thromboembolism (VTE), or blood clots, among hospital patients.

Intermountain was awarded the CDC's HA-VTE Prevention Champion award, which honors the ongoing research and best-practice protocols within Intermountain to prevent hospitalized patients from developing blood clots.

Besides Intermountain, other national VTE champions include: Mayo Clinic, Northwestern Memorial Hospital in Chicago, and Johns Hopkins Hospital in Baltimore.

The purpose of the CDC's recognition program is to encourage other hospitals and health systems to adopt best practices created by the eight VTE champions. The CDC estimates that up to 900,000 venous thromboembolism events occur in the U.S. each year, resulting in as many as 100,000 premature deaths.

VTE-associated healthcare costs may also be as high as $10 billion a year. Without appropriate prevention, it's estimated that as many as 15 percent of hospitalized medical patients will develop hospital-acquired blood clots.

National guidelines recommend VTE-risk assessment protocols for hospitalized medical patients, but they aren't uniformly followed across the nation. Therefore, the CDC began the Healthcare-Associated Venous Thromboembolism Prevention Champion program to recognize health care systems and hospitals that are working to reduce VTE rates and encourage other hospitals to adopt their protocols and best practices.

"Healthcare-associated VTE is a serious and growing public health problem," says Thomas Frieden, MD, MPH, director of the CDC. "These challenge winners saved lives by implementing innovative VTE prevention strategies in their institutions. We can all learn from their ideas and work together to protect patients from developing deadly blood clots."

As part of the protocol, Intermountain Healthcare hospitals utilize an electronic tool that resides in the electronic patient record, which scans the medical record of hospitalized patients daily.

"If a patient is found to be at risk for blood clots, and is not receiving an appropriate medicine to prevent clots, the hospitalist caring for the patient is sent a secure text message alerting them to assure best care is being given," said Scott Woller, MD, co-director of Intermountain Medical Center's Thrombosis Clinic, and principle investigator of the project.

The protocol was launched at Intermountain Medical Center and LDS Hospital, and then implemented at Intermountain's Park City Medical Center, Utah Valley, McKay-Dee, and Riverton hospitals. The initiative is expected to expand across the entire 22-hospital Intermountain Healthcare system.

As part of the initiative, Intermountain hospitalist physicians receive a monthly report on their response to the alerts, their performance, and patient outcomes. Intermountain partnered with Twine Clinical Consulting, LLC, and Medical Impact Ventures, LLC, to create the proprietary audit-and-assessment tools used in the initiative.

"The expertise of Twine Clinical was invaluable in generating the monthly feedback to the individual physicians in an easy-to-use dashboard format that gives them real-time data regarding their personal performance and the resolution of blood clots among patients under their care," Dr. Woller said.

"This groundbreaking work by Dr. Woller and his colleagues shows why Intermountain Healthcare is so effective in improving care and reducing costs," said Mark Ott, MD, chief medical director of Intermountain's Salt Lake Valley hospitals. "By using data to track the care we provide and increase our adherence to proven care processes our patients get better outcomes and avoid the complications that threaten their safety and increase their costs."

The CDC HA-VTE Champions' work will be posted on the CDC's website, shared by the U.S. Agency for Healthcare Research and Quality, and displayed at the 2016 Thrombosis and Hemostasis Summit of North America in April in Chicago.

The Champions range from a small community hospital to some of the country's largest health systems, and they represent both rural and urban areas. Together they cared for more than 450,000 patients admitted to hospitals across the United States in 2014.

They were able to improve VTE prevention within their institutions and organizations by implementing innovative, effective and sustainable VTE prevention strategies, including:
    - Engaging teams of different healthcare experts to support and promote prevention activities.

    - Informing patients and providers about the need for and benefits of VTE prevention.

    - Using technology (such as electronic risk assessment and clinical decision support tools and alerts) to ensure that all patients are assessed for their risk for VTE and bleeding.

    - Providing real-time feedback, scorecards and dashboards for providers and organizations to monitor performance and identify areas for improvement.

For more information and to see profiles of the winners and their initiatives, please visit

Intermountain Medical Center

Related Blood Clots Articles:

Hookah smoke may be associated with increased risk of blood clots
In a new study conducted in mice, researchers found that tobacco smoke from a hookah caused blood to function abnormally and be more likely to clot and quickly form blood clots.
Reducing the risk of blood clots in artificial heart valves
People with mechanical heart valves need blood thinners on a daily basis, because they have a higher risk of blood clots and stroke.
New study finds blood clots more likely in children who receive PICCs
A new study provides convincing evidence that the use of peripherally inserted central catheters (PICCs) to administer medicine and draw blood in children is associated with a significantly increased risk of blood clots (known as venous thromboembolism or VTE) compared with central venous catheters (CVCs) placed directly into the neck or chest.
New study provides insight into the mechanisms of blood clots in cancer patients
Researchers have identified a potential new signaling pathway that may help further the understanding of blood clot formation in cancer patients and ultimately help prevent this complication from occurring.
Cellular senescence is associated with age-related blood clots
Cells that become senescent irrevocably stop dividing under stress, spewing out a mix of inflammatory proteins that lead to chronic inflammation as more and more of the cells accumulate over time.
New guidance on potentially fatal blood clots published today
The European Society of Cardiology (ESC) Guidelines on acute pulmonary embolism are published online today in European Heart Journal, and on the ESC website.
One in five haematological cancer patients suffer blood clots or bleeding
In the years following haematological cancer, one in five survivors suffer a blood clot or bleeding which requires hospital treatment.
Targeting inflammation to better understand dangerous blood clots
Forty percent of people who develop venous thromboembolism don't know what caused it.
Impeding white blood cells in antiphospholipid syndrome reduced blood clots
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.
Research unlocks biomechanical mystery behind deadly blood clots
Researchers at the University of Sydney have used biomechanical engineering techniques to unlock the mystery surrounding the mechanical forces that influence blood clotting.
More Blood Clots News and Blood Clots Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at